KOSS Koss Corp
- Stocks
- Technology
- NASDAQ: KOSS
Price (delayed)
$4.71
Market cap
$44.54M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.01
Enterprise value
$42.05M
Relative Growth:
Rel. Growth:
72
Relative Strength:
Rel. Strength:
18
Relative Valuation:
Rel. Valuation:
16
Relative Profitability:
Rel. Profitability:
42
Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data
Highlights
Koss's EPS has soared by 92% YoY and by 89% from the previous quarter
Koss's net income has soared by 81% YoY and by 76% from the previous quarter
Key stats
What are the main financial stats of KOSS
Market
Valuations
Earnings
Shares outstanding
9.46M
Market cap
$44.54M
Enterprise value
$42.05M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.44
Price to sales (P/S)
3.3
PEG
N/A
EV/EBIT
N/A
EV/EBITDA
615.43
EV/Sales
3.12
Revenue
$13.49M
Gross profit
$5.23M
Operating income
-$1.15M
Net income
-$211,567
EBIT
-$193,486
EBITDA
$68,331
Free cash flow
$211,531
Per share
Balance sheet
Liquidity
EPS
-$0.01
EPS diluted
-$0.01
Free cash flow per share
$0.02
Book value per share
$3.26
Revenue per share
$1.43
TBVPS
$3.98
Total assets
$37.66M
Total liabilities
$6.81M
Debt
$29,344
Equity
$30.86M
Working capital
$20.63M
Debt to equity
0
Current ratio
11.1
Quick ratio
8.53
Net debt/EBITDA
-36.39
Margins
Efficiency
Dividend
EBITDA margin
0.5%
Gross margin
38.8%
Net margin
-1.6%
Operating margin
-8.5%
Return on assets
-0.6%
Return on equity
-0.7%
Return on invested capital
-0.6%
Return on capital employed
-0.5%
Return on sales
-1.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
KOSS stock price
How has the Koss stock price performed over time
Intraday
2.17%
1 week
-3.68%
1 month
-9.25%
1 year
-33.1%
YTD
-36.18%
QTD
-7.28%
Financial performance
How have Koss's revenue and profit performed over time
Revenue
$13.49M
Gross profit
$5.23M
Operating income
-$1.15M
Net income
-$211,567
Gross margin
38.8%
Net margin
-1.6%
Koss's net margin has surged by 83% YoY and by 77% QoQ
Koss's net income has soared by 81% YoY and by 76% from the previous quarter
KOSS's operating margin is up by 50% year-on-year and by 38% since the previous quarter
The operating income has grown by 44% YoY and by 34% from the previous quarter
Price vs fundamentals
How does KOSS's price correlate with its fundamentals
Growth
What is Koss's growth rate over time
Valuation
What is Koss stock price valuation
P/E
N/A
P/B
1.44
P/S
3.3
EV/EBIT
N/A
EV/EBITDA
615.43
EV/Sales
3.12
Koss's EPS has soared by 92% YoY and by 89% from the previous quarter
KOSS's P/B is 50% below its 5-year quarterly average of 2.9 and 15% below its last 4 quarters average of 1.7
The stock's P/S is 23% below its 5-year quarterly average of 4.3 and 20% below its last 4 quarters average of 4.1
KOSS's revenue is up by 12% year-on-year and by 7% since the previous quarter
Efficiency
How efficient is Koss business performance
Koss's ROS has soared by 86% YoY and by 79% from the previous quarter
KOSS's ROIC has soared by 83% YoY and by 77% QoQ
The company's return on equity has surged by 81% YoY and by 75% QoQ
Koss's ROA has soared by 79% YoY and by 74% from the previous quarter
Dividends
What is KOSS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for KOSS.
Financial health
How did Koss financials performed over time
The quick ratio has surged by 52% year-on-year
The current ratio has grown by 36% YoY but it has contracted by 4.7% from the previous quarter
Koss's debt is 100% lower than its equity
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.